Literature DB >> 15660988

Effects of haemophilic arthropathy on health-related quality of life and socio-economic parameters.

K Fischer1, J G Bom, E P Mauser-Bunschoten, G Roosendaal, H M Berg.   

Abstract

Although prophylactic treatment is advised for all children with severe haemophilia, the optimal regimen is still under discussion. Should all joint bleeds be prevented, or can a limited amount of arthropathy be tolerated in adulthood without loss of quality of life? To answer this question, the effect of haemophilic arthropathy on health-related quality of life (HRQoL) needs to be quantified. In a retrospective study, the effect of arthropathy on HRQoL and socio-economic parameters was assessed in a single-centre cohort of 96 patients with severe and moderate haemophilia with a minimum age of 13 years. Arthropathy was measured by the radiological Pettersson score of the elbows, knees and ankles (maximum: 78 points). HRQoL was assessed by the Short Form 36 (SF36), measuring eight domains of health. Labourforce participation and medical consumption were assessed using a separate questionnaire. Patients were studied at a mean age of 28.6 years (range: 13-54), the mean time between evaluation and the last Pettersson score was 0.4 years (SD: 1.1). The overall median Pettersson score was 13 (range: 0-78). There was a trend towards lower quality of life with increasing Pettersson scores and age, especially in the physical domains of the SF36. An age-adjusted analysis showed that arthropathy had a small but significant effect on HRQoL in the domain of 'physical function' of the SF36, but not on its other domains, or on labourforce participation and medical consumption. Thus suggesting that the SF36 can be used to assess the effects of haemophilic arthropathy, especially in the domain of 'physical function'.

Entities:  

Mesh:

Year:  2005        PMID: 15660988     DOI: 10.1111/j.1365-2516.2005.01065.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  11 in total

1.  A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A.

Authors:  Kathelijn Fischer; Maurice E Pouw; Daniel Lewandowski; Mart P Janssen; H Marijke van den Berg; Ben A van Hout
Journal:  Haematologica       Date:  2011-01-27       Impact factor: 9.941

2.  Haemophilia A carriers experience reduced health-related quality of life.

Authors:  L Gilbert; A Paroskie; D Gailani; M R Debaun; R F Sidonio
Journal:  Haemophilia       Date:  2015-04-30       Impact factor: 4.287

3.  Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).

Authors:  T C Abshire; A B Federici; M T Alvárez; J Bowen; M D Carcao; J Cox Gill; N S Key; P A Kouides; K Kurnik; A E Lail; F W G Leebeek; M Makris; P M Mannucci; R Winikoff; E Berntorp
Journal:  Haemophilia       Date:  2012-07-23       Impact factor: 4.287

4.  Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity.

Authors:  Michael Wang; Michael Recht; Neeraj N Iyer; David L Cooper; J Michael Soucie
Journal:  Res Pract Thromb Haemost       Date:  2020-07-06

5.  Quality of Life, Perception of Disease and Coping Strategies in Patients with Hemophilia in Spain and El Salvador: A Comparative Study.

Authors:  Rubén Cuesta-Barriuso; Ana Torres-Ortuño; Joaquín Nieto-Munuera; José Antonio López-Pina
Journal:  Patient Prefer Adherence       Date:  2021-08-21       Impact factor: 2.711

6.  Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea.

Authors:  Byung Suk Moon; Jun Seok Choi; Chur Woo You
Journal:  Korean J Pediatr       Date:  2013-07-19

7.  Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus.

Authors:  Axel Seuser; Claudia Djambas Khayat; Claude Negrier; Adly Sabbour; Lily Heijnen
Journal:  Blood Coagul Fibrinolysis       Date:  2018-09       Impact factor: 1.276

Review 8.  Pathophysiology of Hemophilic Arthropathy.

Authors:  Daniela Melchiorre; Mirko Manetti; Marco Matucci-Cerinic
Journal:  J Clin Med       Date:  2017-06-25       Impact factor: 4.241

9.  Health-Related Quality of Life and Association With Arthropathy in Greek Patients with Hemophilia.

Authors:  Agoritsa Varaklioti; Nick Kontodimopoulos; Dimitris Niakas; Anna Kouramba; Olga Katsarou
Journal:  Clin Appl Thromb Hemost       Date:  2017-10-09       Impact factor: 2.389

10.  Effectiveness of hypnosis for pain management and promotion of health-related quality-of-life among people with haemophilia: a randomised controlled pilot trial.

Authors:  Ana Cristina Paredes; Patrício Costa; Susana Fernandes; Manuela Lopes; Manuela Carvalho; Armando Almeida; Patrícia Ribeiro Pinto
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.